US Patent Issued on Sept. 29 for "Methods of producing microbubble drug conjugates, viral gene therapy microbubble conjugates and targeted microbubbles" (Canadian Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,292, issued on Sept. 29.

"Methods of producing microbubble drug conjugates, viral gene therapy microbubble conjugates and targeted microbubbles" was invented by James Alexander Keenan (Ottawa).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods of producing microbubble drug conjugates, viral gene therapy microbubble drug conjugates, and disease-targeting microbubbles, for clinical and preclinical ultrasound-mediated therapeutic and diagnostic applications. It includes methods to produce viral vector gene therapy microbubble drug conjugates with antibody linkers conjugated to lipid shelled microbubbles that both bi...